INOFEA AG

📍 Muttenz, Switzerland🗓 Founded 2014👥 9 employees💰 Last funded Jun 2017
Biotechnology Research🌐 inofea.com
Website LinkedIn
INOFEA empowers enzymes. Enzyme stabilization and protection is INOFEA`s core business. We have developed an innovative and patented platform technology to provide enzymes with a protective shield. We unlock the full potential value of enzymes, providing a seamless level of enhanced properties, unlike any other existing technology. This makes your enzymes 10 times more stable and they can be re-used easily. Our highly resistant enzymes support Biocatalysis including bioconjugation, diagnostics (bioanalysis) or can be formulated as active ingredients. Our technology addresses a wide range of biotech applications for the industry and demonstrated substantial benefits to customers in pharma, food processing, specialty chemicals and consumer care.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
3
Investor activity2015–2017 · investors recorded per year
2015220171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in INOFEA AG?
INOFEA AG has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did INOFEA AG last raise funding?
The most recent investment in INOFEA AG recorded on gritt.io was in June 2017.
When was INOFEA AG founded?
INOFEA AG was founded in 2014.
What industry is INOFEA AG in?
INOFEA AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is INOFEA AG based?
INOFEA AG is headquartered in Muttenz, Switzerland.